S L Block

Summary

Country: USA

Publications

  1. ncbi Pneumococcal serotypes from acute otitis media in rural Kentucky
    Stan L Block
    Kentucky Pediatric Research, Inc, Bardstown, Luisville, KY, USA
    Pediatr Infect Dis J 21:859-65. 2002
  2. ncbi Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women
    Stan L Block
    Kentucky Pediatric Research, Inc, 201 S 5th St, Bardstown, KY 40004, USA
    Pediatrics 118:2135-45. 2006
  3. pmc Searching for the Holy Grail of acute otitis media
    S L Block
    Kentucky Pediatric Research, Inc, 201 South 5th Street, Bardstown, KY 40004, USA
    Arch Dis Child 91:959-61. 2006
  4. doi A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
    Stan L Block
    Kentucky Pediatric and Adult Research, 201 South 5th Street, Bardstown, KY 40004 1142, USA
    Vaccine 29:9391-7. 2011
  5. ncbi A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, 40004, USA
    Clin Ther 27:786-94. 2005
  6. ncbi Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY 40004, USA
    Curr Med Res Opin 22:1839-47. 2006
  7. pmc Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects
    Stan L Block
    Kentucky Pediatric Research, 201 S 5th St, Bardstown, KY 40004 1142, USA
    Antimicrob Agents Chemother 51:4001-8. 2007
  8. doi Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY 40004, United States
    Vaccine 26:4940-6. 2008
  9. doi Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing
    Stan L Block
    Kentucky Pediatric Research, Bardstown, Kentucky 40004, USA
    Clin Pediatr (Phila) 48:723-33. 2009
  10. doi Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, Kentucky 40004 1142, USA
    Clin Ther 31:2140-7. 2009

Detail Information

Publications33

  1. ncbi Pneumococcal serotypes from acute otitis media in rural Kentucky
    Stan L Block
    Kentucky Pediatric Research, Inc, Bardstown, Luisville, KY, USA
    Pediatr Infect Dis J 21:859-65. 2002
    ..Acute otitis media (AOM) accounts for most infections caused by, but few data are available regarding the incidence of pneumococcal serotypes recovered from children with AOM in the United States...
  2. ncbi Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women
    Stan L Block
    Kentucky Pediatric Research, Inc, 201 S 5th St, Bardstown, KY 40004, USA
    Pediatrics 118:2135-45. 2006
    ..We conducted a noninferiority immunogenicity study to bridge the efficacy findings in young women to preadolescent and adolescent girls and boys, who represent a primary target for human papillomavirus vaccination...
  3. pmc Searching for the Holy Grail of acute otitis media
    S L Block
    Kentucky Pediatric Research, Inc, 201 South 5th Street, Bardstown, KY 40004, USA
    Arch Dis Child 91:959-61. 2006
  4. doi A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
    Stan L Block
    Kentucky Pediatric and Adult Research, 201 South 5th Street, Bardstown, KY 40004 1142, USA
    Vaccine 29:9391-7. 2011
    ..Quadrivalent live attenuated influenza vaccine (Q/LAIV) is an investigational 4-strain formulation of LAIV that contains 2 A strains, A/H1N1 and A/H3N2, and 2 B strains, 1 from each lineage...
  5. ncbi A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, 40004, USA
    Clin Ther 27:786-94. 2005
    ..Short-course therapy for acute otitis media (AOM) improves adherence and may reduce secondary bacterial resistance...
  6. ncbi Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY 40004, USA
    Curr Med Res Opin 22:1839-47. 2006
    ....
  7. pmc Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects
    Stan L Block
    Kentucky Pediatric Research, 201 S 5th St, Bardstown, KY 40004 1142, USA
    Antimicrob Agents Chemother 51:4001-8. 2007
    ..The immunogenicities, reactogenicity events, and AEs were comparable for refrigerated CAIV-T and frozen LAIV...
  8. doi Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY 40004, United States
    Vaccine 26:4940-6. 2008
    ..Live attenuated influenza vaccine (LAIV) is indicated for influenza prevention in persons 2-49 years of age. This study describes the incidence and duration of vaccine virus shedding and serum immune responses after receipt of LAIV...
  9. doi Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing
    Stan L Block
    Kentucky Pediatric Research, Bardstown, Kentucky 40004, USA
    Clin Pediatr (Phila) 48:723-33. 2009
    ..Evening dosing showed greater tolerability with significantly more patients receiving morning atomoxetine reporting at least 1 adverse event than those receiving evening atomoxetine...
  10. doi Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, Kentucky 40004 1142, USA
    Clin Ther 31:2140-7. 2009
    ..Although 2 doses of influenza vaccine are recommended for children aged <9 years who have not been previously vaccinated, children may receive only 1 dose because of suboptimal adherence to national influenza vaccination recommendations...
  11. doi The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children
    Stan L Block
    Kentucky Pediatric and Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 30:203-7. 2011
    ..LAIV is approved for eligible children aged ≥ 2 years in the United States and in several other countries...
  12. ncbi Otitis externa: providing relief while avoiding complications
    Stan L Block
    University of Louisville, Louisville, KY, USA
    J Fam Pract 54:669-76. 2005
  13. ncbi Microbiology of acute otitis media recently treated with aminopenicillins
    S L Block
    Kentucky Pediatric Research, University of Louisville, Louisville, KY, USA
    Pediatr Infect Dis J 20:1017-21. 2001
    ....
  14. ncbi Role of influenza vaccine for healthy children in the US
    Stan L Block
    Kentucky Pediatric Research, Bardstown, Kentucky 40004, USA
    Paediatr Drugs 6:199-209. 2004
    ..The practitioner must consider the benefits of FluMist compared with its likely higher vaccine cost and the issues of reimbursement among multiple insurers...
  15. pmc Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998)
    S L Block
    Kentucky Pediatric Research, Inc, Bardstown, Kentucky 40004, USA
    Antimicrob Agents Chemother 44:1650-4. 2000
    ..Penicillin-nonsusceptible S. pneumoniae was observed in 32% of 65 patients with S. pneumoniae conjunctivitis, with most strains being penicillin resistant...
  16. ncbi Restricted use of antibiotic prophylaxis for recurrent acute otitis media in the era of penicillin non-susceptible Streptococcus pneumoniae
    S L Block
    FAAP, Kentucky Pediatric Research, Inc, 201 South 5th Street, Bardstown, KY 40004, USA
    Int J Pediatr Otorhinolaryngol 61:47-60. 2001
    ....
  17. ncbi Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media
    Stan L Block
    Kentucky Pediatric Research, Inc, Bardstown, KY, USA
    Pediatr Infect Dis J 23:829-33. 2004
    ....
  18. doi Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine
    Stan L Block
    Kentucky Pediatric Adult Research, Inc, Bardstown, KY 40004, USA
    Pediatr Infect Dis J 29:95-101. 2010
    ..We describe the safety of the human papillomavirus (HPV)-6/11/16/18 vaccine using updated clinical trial data (median follow-up time of 3.6 years) and summarize up to 3 years of post-licensure surveillance...
  19. doi Post hoc analysis: early changes in ADHD-RS items predict longer term response to atomoxetine in pediatric patients
    Stan L Block
    Kentucky Pediatric Research, Bardstown, KY, USA
    Clin Pediatr (Phila) 49:768-76. 2010
    ..2% and 77.5%), or by the combination of items 1 and 10 (PPVs: 75.1% and 75.4%; NPVs: 72.2% and 77.5%; training and validation data sets, respectively)...
  20. ncbi Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY, USA
    Pediatr Infect Dis J 23:834-8. 2004
    ..Short course beta-lactam antibiotic therapy for acute otitis media (AOM) should improve patient adherence, but it has not been evaluated since the heptavalent pneumococcal conjugate vaccine became routinely used in the United States...
  21. doi Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine
    Kristina A Bryant
    Department of Pediatrics, University of Louisville, Louisville, KY 40292, USA
    Pediatrics 125:866-75. 2010
    ..The safety and immunogenicity of PCV7 were compared with those of 13-valent PCV (PCV13), which contains saccharides from serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F conjugated to CRM(197)...
  22. ncbi Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, Kentucky, USA
    Pediatrics 119:11-8. 2007
    ..Rotavirus is the leading cause of dehydrating acute gastroenteritis in infants worldwide. Previous studies of a live pentavalent human-bovine reassortant rotavirus vaccine have shown it to be efficacious across a range of potencies...
  23. ncbi Oral beta-lactams in the treatment of acute otitis media
    Stan L Block
    Kentucky Pediatric Adult Research, Bardstown, KY, USA
    Diagn Microbiol Infect Dis 57:19S-30S. 2007
    ..influenzae and S. pneumoniae...
  24. ncbi Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA) in rural Kentucky children
    S L Block
    Kentucky Pediatric Research, Inc, Bardstown 40004
    Pediatr Infect Dis J 12:976-80. 1993
    ..The rise in geometric mean titers after the booster dose was > 120-fold and was highest in the recipients of the 25-unit Nunc cell lot (P < 0.05 for Group C vs. B).(ABSTRACT TRUNCATED AT 250 WORDS)..
  25. ncbi Therapeutic nihilists: lend me your ears, or the witches' cauldron of acute otitis media
    Stan L Block
    Kentucky Pediatric Research, Inc, 201 South 5th Street, Bardstown, KY 40004, USA
    Pediatr Ann 31:784-91; quiz 783, 821-3. 2002
  26. ncbi Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients
    Stan L Block
    201 South 5th Street, Bardstown, KY 40004, USA
    Clin Pediatr (Phila) 45:641-8. 2006
    ..The overall cure rate exceeded 90% for each treatment group. Discontinuation rates and adverse events were 4.5% and 24.6%, respectively...
  27. ncbi Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial
    Benjamin Torum
    CIDAL, Guatemala City, Guatemala
    Clin Ther 26:1046-54. 2004
    ..3% solution for 10 days has been reported to be as effective and well tolerated as the standard of care, neomycin sulfate/polymyxin B sulfate/hydrocortisone solution administered 4 times daily for 10 days...
  28. ncbi New data on influenza vaccines in children
    Stan L Block
    Pediatr Infect Dis J 23:85. 2004
  29. pmc High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media
    Antonio Arrieta
    Children s Hospital of Orange County, Orange, California, USA
    Antimicrob Agents Chemother 47:3179-86. 2003
    ..095). Corresponding compliance rates were 99 and 93%, respectively (P = 0.018). These data demonstrate the efficacy and safety of high-dose azithromycin for treating recurrent or persistent AOM...
  30. doi Characteristics of an ideal rotavirus vaccine
    Keith S Reisinger
    Primary Physicians Research, Pittsburgh, Pennsylvania 15241, USA
    Clin Pediatr (Phila) 47:555-63. 2008
    ..Vaccination against rotavirus will substantially reduce rotavirus gastroenteritis-associated morbidity and mortality and, in so doing, bring about a significant reduction in rotavirus gastroenteritis-associated healthcare utilization...
  31. doi Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age
    Terry Nolan
    School of Population Health, University of Melbourne and Murdoch Children s Research Institute, Carlton, Melbourne, Victoria 3010, Australia
    Pediatrics 121:508-16. 2008
    ..This study evaluated the safety, tolerability, and immunogenicity of live attenuated influenza vaccine administered concurrently with measles-mumps-rubella vaccine and varicella vaccine to healthy children 12 to 15 months of age...
  32. ncbi Acute otitis media: bunnies, disposables, and bacterial original sin!
    Stan L Block
    Pediatrics 111:217-8; author reply 217-8. 2003
  33. ncbi Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial
    Keith S Reisinger
    Primary Physicians Research, Pittsburgh, PA, USA
    Pediatr Infect Dis J 26:201-9. 2007
    ..We evaluated the tolerability and immunogenicity of quadrivalent vaccine in males and females 9 to 15 years of age through 18 months postenrollment...